Andrew Poklepovic

Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma

Sapna P. Patel, Megan Othus, Yuanbin Chen et al. · New England Journal of Medicine · 2023 · 741 citations · Full text

Population-based risk factors and resource utilization for HCC: US perspective

Arun J. Sanyal, Andrew Poklepovic, Érick Moyneur et al. · Current Medical Research and Opinion · 2010 · 306 citations

Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma

Daniel J. Olson, Zeynep Eroglu, Bruce Brockstein et al. · Journal of Clinical Oncology · 2021 · 214 citations · Full text

Insulin Activates Protein Kinases C-ζ and C-λ by an Autophosphorylation-dependent Mechanism and Stimulates Their Translocation to GLUT4 Vesicles and Other Membrane Fractions in Rat Adipocytes

Mary L. Standaert, Gautam Bandyopadhyay, Liliam Perez et al. · Journal of Biological Chemistry · 1999 · 209 citations · Full text

Insulin Signaling, Insulin Activates Protein, Truncated Pkc-zeta +18

HDAC inhibitors enhance the immunotherapy response of melanoma cells

Laurence Booth, Jane L. Roberts, Andrew Poklepovic et al. · Oncotarget · 2017 · 132 citations · Full text

Hdac Inhibitors, Tumor Immunology, Melanoma Isolates +10